Kyoto University eyes providing gene-edited iPS cells from 2023

A Kyoto University foundation is preparing to provide induced pluripotent stem cells, or iPS cells, for medical use from next March, using cells that have the reduced risk of transplant rejection thanks to the gene-editing tool CRISPR, a foundation official said Sunday.The CiRA Foundation, an offshoot of the university's Center for iPS Cell Research and Application, plans to increase the types of iPS cells it has, with the view to increasing the stock of cells that match nearly all Japanese and 95 percent of the world's population.The Kyoto-based foundation has already developed iPS cells u…READ FULL ARTICLE